Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Attovia Therapeutics, Inc. before investing.

In this article, we go over a few key elements for understanding Attovia Therapeutics, Inc.’s stock price such as:

• Attovia Therapeutics, Inc.’s current stock price and volume
• Why Attovia Therapeutics, Inc.’s stock price changed recently
• Upgrades and downgrades for ATTO from analysts
• ATTO’s stock price momentum as measured by its relative strength

About Attovia Therapeutics, Inc. (ATTO)

Before we jump into Attovia Therapeutics, Inc.’s stock price, history, target price and what caused it to recently , let’s take a look at some background.

Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments. The company’s products include ATTO-1310, a novel ATTOBODY-based Fc-fusion protein therapeutic that inhibits IL-31; developed for the treatment of chronic pruritic diseases such as CPUO, high-itch AD, cholestatic pruritus, and CKD-aP; ATTO-2306, an ATTOBODY-based, half-life-extended immunoglobulin G (IgG)-fusion protein therapeutic that inhibits IL-13 and IL-31; developed for the treatment of AD and other immune-mediated skin diseases, such as CSU and PN; and ATTO-1091, a trispecific ATTOBODY-based Fc-fusion protein therapeutic that inhibits TL1A, IL-23, and integrin a4ß7; developed for IBD a chronic immune-mediated condition characterized by persistent inflammation of the gastrointestinal tract, includes ulcerative colitis (UC) and crohn’s disease (CD). The company was incorporated in 2022 and is based in San Carlos, California.

Want to learn more about Attovia Therapeutics, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Attovia Therapeutics, Inc..

Attovia Therapeutics, Inc.’s Stock Price as of Market Close

As of September 16, 2026, 4:00 PM, CST, Attovia Therapeutics, Inc.’s stock price was $22.250.

Attovia Therapeutics, Inc. is 0% from its previous closing price of $22.250.

During the last market session, Attovia Therapeutics, Inc.’s stock traded between $21.235 and $24.570. Currently, there are approximately 4.24 million shares outstanding for Attovia Therapeutics, Inc..

Attovia Therapeutics, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Attovia Therapeutics, Inc. Stock Price History

Attovia Therapeutics, Inc.’s (ATTO) price is currently up 3.97% so far this month.

During the month of September, Attovia Therapeutics, Inc.’s stock price has reached a high of $28.000 and a low of $20.200.

Over the last year, Attovia Therapeutics, Inc. has hit prices as high as $28.000 and as low as $16.150.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Attovia Therapeutics, Inc. Stock’s Price to ?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 16, 2026, there were analysts who downgraded Attovia Therapeutics, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Attovia Therapeutics, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Attovia Therapeutics, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Attovia Therapeutics, Inc. (ATTO) by visiting AAII Stock Evaluator.

Relative Price Strength of Attovia Therapeutics, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 16, 2026, Attovia Therapeutics, Inc. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Attovia Therapeutics, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Attovia Therapeutics, Inc. Stock Price: Bottom Line

As of September 16, 2026, Attovia Therapeutics, Inc.’s stock price is $22.250, which is 0% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Attovia Therapeutics, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.